Proteasomes and proteasome inhibition in the central nervous system

Free Radical Biology and Medicine

Volumn 31, Issue 5, 2001, Pages 574-584

  Ding, Qunxing ^a   Keller, Jeffrey N ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Central nervous system; Free radicals; Heat shock protein; Oxidative stress; Proteasome

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN; CYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING); ESTROGEN RECEPTOR ALPHA; HEAT SHOCK PROTEIN; HISTONE; INTERLEUKIN RECEPTOR; OPIATE RECEPTOR; PRESENILIN 1; PROTEASOME; PROTEIN P53;

AGING; ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; ENZYME SUBUNIT; HUMAN; ISCHEMIA; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BRAIN; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; MULTIENZYME COMPLEXES; NEURODEGENERATIVE DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; REACTIVE OXYGEN SPECIES;

EID: 0035451913     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(01)00635-9     Document Type: Review

References (127)

1. The 26S proteasome: A machine designed for controlled proteolysis
2. Proteasomes: Structure and biology
3. New insights into the mechanisms and importance of the proteasome in intracellular protein degradation
4. The proteasome: A protein-destroying machine
5. The ubiquitin-proteasome proteolytic pathway
6. Proteasomes: Multicatalytic proteinase complexes
7. The proteasome, a novel protease regulated by multiple mechanisms
8. Degradation of oxidized proteins in mammalian cells
9. Proteolysis of oxidized proteins and cellular senescence
10. Aggresomes: A cellular response to misfolded proteins
11. Poly- ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones
12. Cyclin is degraded by the ubiquitin pathway
13. Ubiquitination of the G1 cyclin Cln2 by Cdc34p-dependent pathway
14. Cdc28-mediated control of Cln3 cyclin degradation
15. Role of ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins
16. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway
17. Stimulation-dependent IkBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway
18. The E6 oncoprotein encoded by human papillomaravirus types 16 and 18 promotes the degradation of p53
19. Multiple C- terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation
20. Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase II alpha expression
21. Parkin is metabolized by the ubiquitin/proteasome system
22. Dual roles of proteasome in the metabolism of presenilin 1
23. Cytoplasmic presenilin aggregates in proteasome inhibitor-treated cells
24. Proteasome contributes to the alpha-secretase pathway of amyloid precursor protein in human cells
25. A distinct ER/IC gamma- secretase competes with the proteasome for cleavage of APP
26. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen-alpha transactivation
27. Proteasome involvement in agonist-induced down regulation of Mu and Delta opiod receptors
28. Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoietin
29. Down- regulation of types I, II and III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin/proteasome pathway
30. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotein B in permeabilized HepG2 cells
31. Two mRNAs exist for the Hs PROS-30 gene encoding a component of human prosomes
32. Molecular cloning and sequence analysis of cDNAs for five major subunits of human proteasomes (multi-catalytic proteinase complexes)
33. Microsequences of 145 proteins recorded in the two- dimensional gel protein database of normal human epidermal keratinocytes
34. The prosomal RNA-binding protein p27K is a member of the alpha-type human prosomal gene family
35. Sequence analyses and inter- species comparisons of three novel human proteasomal subunits, HsN3, HsC7-I and HsC10-II, confine potential proteolytic active-site residues
36. cDNA cloning and interferon gamma down-regulation of proteasomal subunits X and Y
37. The primary structures of four subunits of the human, high-molecular-weight proteinase, macropain (proteasome), are distinct but homologous
38. Structure and functions of the 20S and 26S proteasomes
39. The major histocompatibility complex-encoded proteasome component LMP7: Alternative first exons and post-translational processing
40. Major histocompatibility-encoded human proteasome LMP2. Genomic organization and a new form of mRNA
41. Constitutive and interferon-gamma- induced expression of the human proteasome subunit multicatalytic endopeptidase complex-like 1
42. Subunit 4 of the 26 S protease is a member of a novel eukaryotic ATPase family
43. New human gene encoding a positive modulator of HIV Tat-mediated transactivation
44. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes
45. cDNA cloning of a new putative ATPase subunit p45 of the human 26S proteasome, a homolog of yeast transcriptional factor Sug1p
46. cDNA cloning of p42, a shared subunit of two proteasome regulatory proteins, reveals a novel member of the AAA protein family
47. CDNA cloning of p112, the largest regulatory subunit of the human 26S proteasome, and functional analysis of its yeast homologue, sen3p
48. cDNA cloning and functional analysis of the p97 subunit of the 26S proteasome, a polypeptide identical to the type-1 tumor-necrosis-factor-receptor-associated protein-2/55
49. Molecular cloning and expression of a pituitary gland protein modulating intestinal fluid secretion
50. Purification and characterization of the antisecretory factor: A protein in the central nervous system and in the gut which inhibits intestinal hypersecretion induced by cholera toxin
51. Molecular cloning and expression of a 26 S protease subunit enriched in dileucine repeats
52. Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1
53. cDNA cloning of p40, a regulatory subunit of the human 26S proteasome, and a homolog of the Mov-34 gene product
54. Nin1p, a regulatory subunit of the 26S proteasome, is necessary for activation of Cdc28p kinase of Saccharomyces cerevisiae
55. cDNA cloning and characterization of a human proteasomal modulator subunit, p27 (PSMD9)
56. Molecular cloning and expression of subunit 9 of the 26S proteasome
57. cDNA cloning and functional analysis of p44.5 and p55, two regulatory subunits of the 26S proteasome
58. cDNA cloning and functional analysis of p28 (Nas6p) and p40.5(Nas7p), two novel regulatory subunits of the 26S proteasome
59. Interferon-gamma up-regulates a unique set of proteins in human keratinocytes. Molecular cloning and expression of the cDNA encoding the RGD-sequence-containing protein IGUP I-5111
60. Primary structures of two homologous subunits of PA28, a gamma-interferon- inducible protein activator of the 20S proteasome
61. A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21
62. Biochemical analysis of proteasomes from mouse microglia: Induction of immunoproteasomes by interferon-gamma and lipopolysaccharide
63. Cytokine induced changes in proteasome subunit composition are concentration dependent
64. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: A newly discovered mechanism for modulating the multicatalytic proteanase complex
65. Biochemical purification of distinct proteasome subsets
66. Tissue distribution of constituative proteasomes, immunoproteasomes, and PA28 in rats
67. Immunohistochemical distribution and electron microscopic subcellular localization of the proteasome in the rat CNS
68. Persistent activation of camp dependent protein kinase by regulated proteolysis suggests a neuron-specific function of the ubiquitin system in Aplysia
69. Regulated protein degradation in mitochondria
70. ATP-dependent proteases that also chaperone protein biogenesis
71. The 19S regulatory complex of the proteasome functions independently of proteolysis in nucleotide excision repair
72. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis
73. Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury
74. Impaired proteasome function in Alzheimer's disease
75. Defective ubiquitination of cerebral proteins in Alzheimer's disease
76. Proteasomal function is impaired in substantia nigra in Parkinson's disease
77. Possible involvement of proteasome inhibition in aging: Implications for oxidative stress
78. Decreased levels of proteasome activity and proteasome expression in aging spinal cord
79. Age-related changes in the 20S and 26S proteasome activities in the liver of male F344 rats
80. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells
81. Age-related alterations of proteasome structure and function in aging epidermis
82. Reversible effects of long-term caloric restriction on protein oxidative damage
83. Dietary self-selection can compensate an age-related decrease of rat liver 20S proteasome activity observed with standard diet
84. Fibroblast cultures from healthy centenarians have an active proteasome
85. Multicatalytic proteinase is present in Lewy bodies and neurofibrillary tangles in Lewy body disease brains
86. Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: An immunocytochemical study with light and electron microscopy
87. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly
88. Stress and molecular chaperones in disease
89. Glutamine repeats and neurodegeneration
90. Polyglutamine expansions: Proteolysis, chaperones, and the dangers of promiscuity
91. Protein aggregation and pathogenesis of Huntington's disease: Mechanisms and correlations
92. Ubiquitin, cellular inclusions and their role in neurodegeneration
93. Dopamine induces proteasome inhibition in neural PC12 cell line
94. Activation of the cell death program by nitric oxide involves inhibition of the proteasome
95. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome
96. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein
97. 4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: Possible importance in Alzheimer's disease
98. Comparative resistance of the 20S and 26S proteasome to oxidative stress
99. Activation of the multicatalytic endopeptidase by oxidants. Effects on enzyme structure
100. The neuroprotective potential of heat shock protein 70 (HSP70)
101. The stress gene response in brain
102. Molecular chaperone function of mammailian Hsp70 and Hsp40 - A review
103. Role of molecular chaperones in the nervous system
104. Regulation of the heat shock conjugate Hsc70 in the mammalian cell: The characterization of the anti-apoptotic protein BAG-1 provides novel insights
105. Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90
106. The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome
107. Proteasome inhibition in oxidative stress neurotoxicity: Implications for heat shock proteins
108. cDNA cloning, expression, and functional characterization of PI31, a proline-rich inhibitor of the proteasome
109. The proteasome inhibitor PI31 competes with PA28 for binding to 20S proteasomes
110. Proteasome inhibition results in increased poly-ADP-ribosylation: Implications for neuron death
111. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons
112. p53-dependent induction of apoptosis by proteasome inhibitors
113. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells
114. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release
115. Depolarization regulates cyclin D1 degradation and neuronal apoptosis: A hypothesis about the role of the ubiquitin/proteasome signalling pathway
116. Central nervous system DNA fragmentation induced by the inhibition of nuclear factor kappa B
117. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells
118. Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis
119. Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons
120. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons
121. Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytic pathway
122. Possible role of NF-kappaB and p53 in the glutamate- induced pro-apoptotic neuronal pathway
123. Roles of nuclear factor kappaB in neuronal survival and plasticity
124. Modulation of the PA28alpha-20S proteasome interaction by a peptidyl alcohol
125. Synthetic peptide-based activators of the proteasome
126. Kinetic mechanism of activation by cardiolipin (diphosphatidylglycerol) of the rat liver multicatalytic proteinase
127. RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: A negative feedback circuit